Salmonella typhi represent a critical public health issue worldwide. Plant-derived agents are credible sources for search and development of alternative antimicrobials to fight these infections. This study describes the in-vitro antibacterial activity of plants extracts from 15 medicinal plants of the Cameroonian pharmacopeia against Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa and Salmonella typhi. Plants selected based on their ethnopharmacological uses were extracted by either maceration or decoction using distilled water, ethanol, methanol and ethylacetate. The afforded extracts were phytochemically screened for bioactive secondary metabolites. The microdilution method was used to assess the antibacterial activity. The two promising extracts were tested in combination using the checkboard technique. Eighty one extracts showed antibacterial activity with eight having minimum inhibitory concentrations below 2.5 mg/mL. Results from combination assays with extracts from Terminalia catappa and Gnidia glauca leaves showed synergistic effect against Escherichia coli, Pseudomonas aeruginosa and Salmonella typhi and additive effect against Staphylococcus aureus. These extracts mainly contained saponins, tannins, glucosides, phenols, triterpenes and anthraquinones. These results support the ethnobotanical claims and indicate further directions for the investigation of plants extracts to develop alternative drugs against multi-resistant bacteria.
Introduction


Multi-drug resistant microbial infections caused by Gram-positive bacteria (such as Staphylococcus aureus)
and Gram-negative (such as Escherichia coli, Pseudomonas aeruginosa and Salmonella typhi) represent an exponentially growing health problem affecting communities worldwide [1] [2] [3] . In recent years, they emerged as an important nosocomial pathogen due to multiple drug resistant mechanisms [4] . They cause a variety of infections that include pneumonia, wound, urinary tract, bloodstream and intra-abdominal infections [5] . The Gram-positive Staphylococcus aureus, when pathogenic, is a common cause of skin infections (e.g., boils), respiratory disease (e.g., sinusitis) and food poisoning. Disease-associated strains often promote infections by producing potent protein toxins and expressing cell-surface proteins that bind and inactivate antibodies. The emergence of antibiotic-resistant forms of pathogenic Staphylococcus aureus (e.g., MRSA (methicillin-resistant Staphylococcus aureus)) is a worldwide problem in clinical medicine. The following Gram-negative bacteria also exact a heavy toll. Virulent strains of Escherichia coli can cause gastroenteritis, urinary tract infections and neonatal
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Escherichia coli, Pseudomonas aeruginosa and Salmonella typhi 534 meningitis. In Cameroon, these infections are increasing with children being the most affected. In rarer cases, virulent strains are also responsible for hemolytic-uremic syndrome, peritonitis, mastitis, septicemia and Gram-negative pneumonia. Pseudomonas aeruginosa is a common bacterium that can cause disease in animals, including humans. It is found in soil, water, skin flora and most man-made environments throughout the world. As an opportunistic, nosocomial pathogen of immunocompromised individuals, Pseudomonas aeruginosa typically infects the pulmonary tract, urinary tract, burns, wounds and also causes other blood infections. Salmonella bacteria are zoonotic and can be transferred between humans and other animals. Many infections are due to ingestion of contaminated food. Salmonella, such as Salmonella enterica subsp. enterica serovar typhi, can cause serious illness. Salmonella typhi is adapted to humans and does not occur in other animals [6] [7] [8] [9] . The used synthetic antibiotics are costly and are out of range from the patient belonging to developing countries, the microorganism develop resistance against antibiotics and the antibiotics may be associated with adverse effects on the host, including hypersensitivity, immune suppression and also allergic reactions. Due to the side effects and the resistance built by pathogens against antibiotics, much attention has been paid to extract and bioactive compounds from plants used in herbal medicine [5, 10] . Cameroon has a rich biodiversity and established tradition in the use of herbal medicine for the treatment of various diseases [11] . The screening of plant extracts and phytochemicals for antimicrobial activity has shown that higher plants, especially their secondary metabolites, are a source of structurally diverse bioactive compounds with a wide range of pharmacological activities [12, 13] .
In a search for alternative medicines against bacterial infections, this study was designed to investigate the in-vitro antibacterial activity of extracts from 15 were macerated in 1 L capacity glass bottle using distilled water, 95% ethanol, 70% ethanol and methanol. Sizygium aromaticum, Xantozylum xanthozoloides and Gnidia glauca were extracted by decoction. Viscum album was also macerated in ethyl acetate. The samples were periodically stirred in the mornings and evenings per day using a mechanical shaker. The extracts were filtered using filter paper (Whatman paper No. 1), and concentrated under vacuum using a rotary evaporator (Rotavapor BUCHI 071). Water extract were dried under ventilation. The extracts obtained were stored at 4 °C in the refrigerator until bioassay.
Material and Methods
Collection and Extraction of Plant Materials
Phytochemical Screening
The extracts with promising activity were subjected to phytochemical screening to detect the presence of [14] .
Antioxidant [15] antidiabetic [16] and toxicity [17] Leaf The MIC was determined according to CLSI (Clinical Laboratory Standards Institute) M07-A9 microdilution method, using 96 wells microtitre plates. 148 µL of Nutrient Broth "E" (Lab M Limited Topley House) was introduced in the wells of Column 1 (1A-1H), and 100 µL in the remaining wells. Later on, 52 µL of stock solution of plants extracts at 100 mg/mL were added to the first well. The medium and sample in the first well were mixed thoroughly and serially diluted by transferring 100 μL from wells of Column 1 to wells of Column 2, and so until Column 11. Plant extracts concentration range from 20 mg/mL to 0.01953 mg/mL. Chloramphenicol was used as positive control in each microtitre plate with the concentration ranging from 10 mg/mL to 0.09765 mg/mL. Thereafter, 20 µL of the inoculums were introduced each well containing the test substances except the blank consisting of wells in Column12. After an incubation period at 37 °C for 24 h, turbidity was observed as indication of growth. Thus, the lowest concentration inhibiting the growth of bacteria was recorded as the MIC. Each experiment was performed in duplicates.
Effect of Increase Inoculums Size on MIC (Minimal Inhibitory Concentration)
The extracts with MIC of less than or equal to 5 mg/mL were used to explore the effect of inoculum size two times greater than that use in the first MIC determination (2 × 10 8 CFU/mL) using previously describe procedure. 
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Results
The different results were statistically analysed using the software SPSS 17.0 for windows and variance analysis by ANOVA coupled with Turkey test, where p < 0.05 was considered as statistically significant.
Minimal Inhibitory Concentration of Extracts
The MIC ranged from 0.625 to 20 mg/mL (Table 2) and vary with plants materials, plants part and extraction procedure. The most active extract from these plant are ethanolic extract of A. indica stem, aqueous extract of T. catappa leaves and decoction of G. glauca leaves. This activity could be due to the nature of secondary metabolites present in the plant part and the solvent used for extraction. In fact, the capacity of extraction and solubilisation of solvent is different towards the secondary metabolites.
Twenty extracts inhibited the growth of the four strains at MIC ≤ 5mg/mL. Out of 81 extracts tested eight (AIsbEtOH, AIstEtOH, GGldecoc, TCl water, TCH 2 O/EtOH, TClEtOH, TCsbEtOH and TCtwH 2 O/EtOH) with MIC less or equal to 2.5 mg/mL on four strains were selected to determine the effect of double size inoculum ( Table 3) .
The MIC of the eight tested extracts ranged from 2.5 to 10 mg/mL (Table 3) . Seven extracts inhibited the growth of the four strains with ≤ 5 mg/mL and one extract inhibited with 10 mg/mL on three strains. The extracts with MIC ≤ 2.5 mg/mL on the four strains were selected and tested for combination consisting of GGldecoc (decoction of G. glauca leaf) and TClH 2 O (aqueous extract of T. catappa leaf).
MIC (Minimal Inhibitory Concentration) of Extract Combination Tests
The checkerboard assay was conducted using the decoction of G. glauca leaf and aqueous extract of T. catappa leaf against bacteria strains (Table 4 ). This method supports evidence for synergy, competition or antagonism for selected compounds as it is reflected by the FICI. A FICI of ≤ 0.5 indicates synergistic interaction. These plant extracts increased their respective antibacterial activity against the tested strains. Synergism effect was observed on Escherichia coli, Pseudomonas aeruginosa, Salmonella typhi and additive effect on Staphylococcus aureus with the two plant extracts. The mean FIC indices ranged from 0.33 to 0.68 on the four bacteria strains (Table 4) .
Phytochemical Composition of the Two Extracts
Phytochemical screening revealed the presence of saponins, tannins, glucosides, phenols, triterpenes and anthraquinones in both extracts. Alkaloids and steroids were present only in the aqueous extract of T. catappa leaf and flavonoids in the decoction of G. glauca leaf (Table 5 ).
Discussion
This study was carried out on various plant extracts chosen on the ethnopharmacological basis where their efficacy for century's usage was verified in many cases by scientific studies ( Table 1 10.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 10.00 ± 0.00 VAstMeOH 20.00 ± 0.00 10.00 ± 0.00 10.00 ± 0.00 20.00 ± 0.00 VAtrAcet > 20.00 ± 0.00 > 20.00 ± 0.00 20.00 ± 0.00 20.00 ± 0.00 VAtrEtOH(50%) > 20.00 ± 0.00 10.00 ± 0.00 20.00 ± 0.00 20.00 ± 0.00 VAtrEtOH(70%)
10.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 VAtrH 2 O 10.00 ± 0.00 10.00 ± 0.00 10.00 ± 0.00 10.00 ± 0.00 VAtrMeOH 20.00 ± 0.00 10.00 ± 0.00 10.00 ± 0.00 10.00 ± 0.00 AIlH 2 O 10.00 ± 0.00 2.50 ± 0.00 10.00 ± 0.00 10.00 ± 0.00 AIlH 2 O/EtOH 10.00 ± 0.00 5.00 ± 0.00 10.00 ± 0.00 10.00 ± 0.00 AIsbEtOH 2.50 ± 0.00 5.00 ± 0.00 2.50 ± 0.00 1.25 ± 0.00 AIsbH 2 O 2.50 ± 0.00 5.00 ± 0.00 10.00 ± 0.00 2.50 ± 0.00 AIstEtOH 2.50 ± 0.00 5.00 ± 0.00 1.25 ± 0.00 1.25 ± 0.00 GGbadecoc 5.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 GGlH 2 O 5.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 GGldecoc 5.00 ± 0.00 2.50 ± 0.00 2.50 ± 0.00 2.50 ± 0.00 GGtwH 2 O 5.00 ± 0.00 5.00 ± 0.00 10.00 ± 0.00 5.00 ± 0.00 HLfldecoc 5.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 HLlH 2 O 5.00 ± 0.00 5.00 ± 0.00 10.00 ± 0.00 10.00 ± 0.00 HLlWMeOH 5.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 10.00 ± 0.00 HLlNWMeOH 10.00 ± 0.00 20.00 ± 0.00 5.00 ± 0.00 20.00 ± 0.00 HLtw+stWMeOH 20.00 ± 0.00 20.00 ± 0.00 20.00 ± 0.00 20.00 ± 0.00 HyLtw+stSWMeOH 20.00 ± 0.00 20.00 ± 0.00 20.00 ± 0.00 20.00 ± 0.00 MMtwdecoc 20.00 ± 0.00 5.00 ± 0.00 10.00 ± 0.00 20.00 ± 0.00 MTbr 5.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 10.00 ± 0.00 MTbrEtOH 10.00 ± 0.00 5.00 ± 0.00 1.25 ± 0.00 20.00 ± 0.00 MTbrH 2 O 10.00 ± 0.00 10.00 ± 0.00 10.00 ± 0.00 5.00 ± 0.00 MTbrH 2 O/EtOH 10.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 MTl 5.00 ± 0.00 5.00 ± 0.00 10.00 ± 0.00 10.00 ± 0.00 MTlH 2 O/EtOH 10.00 ± 0.00 5.00 ± 0.00 2.50 ± 0.00 20.00 ± 0.00 MTlEtOH > 20.00 ± 0.00 > 20.00 ± 0.00 > 20.00 ± 0.00 > 20.00 ± 0.00 MTlH 2 O 5.00 ± 0.00 5.00 ± 0.00 2.50 ± 0.00 2.50 ± 0.00 MTpe 10.00 ± 0.00 5.00 ± 0.00 20.00 ± 0.00 20.00 ± 0.00 MTpeH 2 O/EtOH 10.00 ± 0.00 10.00 ± 0.00 20.00 ± 0.00 20.00 ± 0.00 MTpu 10.00 ± 0.00 10.00 ± 0.00 10.00 ± 0.00 5.00 ± 0.00 MTpuH 2 O/EtOH 10.00 ± 0.00 > 20.00 ± 0.00 5.00 ± 0.00 20.00 ± 0.00 MTpuEtOH > 20.00 ± 0.00 10.00 ± 0.00 10.00 ± 0.00 > 20.00 ± 0.00 MTpuH 2 O 20.00 ± 0.00 20.00 ± 0.00 10.00 ± 0.00 10.00 ± 0.00 MTse 10.00 ± 0.00 10.00 ± 0.00 20.00 ± 0.00 20.00 ± 0.00 MTseH 2 O 10.00 ± 0.00 20.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 MTseH 2 O/EtOH > 20.00 ± 0.00 > 20.00 ± 0.00 > 20.00 ± 0.00 > 20.00 ± 0.00 MTseEtOH 10.00 ± 0.00 > 20.00 ± 0.00 > 20.00 ± 0.00 > 20.00 ± 0.00 MTtw 5.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 MTtwH2O/EtOH 5.00 ± 0.00 2.50 ± 0.00 5.00 ± 0.00 2.50 ± 0.00 MTtwEtOH > 20.00 ± 0.00 > 20.00 ± 0.00 20.00 ± 0.00 > 20.00 ± 0.00 MTtwH 2 O 10.00 ± 0.00 10.00 ± 0.00 10.00 ± 0.00 5.00 ± 0.00 PClEtOH 10.00 ± 0.00 20.00 ± 0.00 20.00 ± 0.00 10.00 ± 0.00 PSlEtOH > 20.00 ± 0.00 > 20.00 ± 0.00 > 20.00 ± 0.00 > 20.00 ± 0.00 PSsbEtOH 20.00 ± 0.00 20.00 ± 0.00 10.00 ± 0.00 5.00 ± 0.00 PStrEtOH > 20.00 ± 0.00 20.00 ± 0.00 > 20.00 ± 0.00 20.00 ± 0.00 SAse 2.50 ± 0.00 1.25 ± 0.00 2.50 ± 0.00 10.00 ± 0.00 TClH 2 O 5.00 ± 0.00 1.25 ± 0.00 0.625 ± 0.00 2.50 ± 0.00 2.50 ± 0.00 5.00 ± 0.00 2.50 ± 0.00 2.50 ± 0.00 TCsbH 2 O/EtOH 10.00 ± 0.00 5.00 ± 0.00 20.00 ± 0.00 5.00 ± 0.00 TCstEtOH 5.00 ± 0.00 5.00 ± 0.00 10.00 ± 0.00 2.50 ± 0.00 TCstH 2 O/EtOH 5.00 ± 0.00 1.25 ± 0.00 1.25 ± 0.00 2.50 ± 0.00 UClEtOH 20.00 ± 0.00 20.00 ± 0.00 20.00 ± 0.00 20.00 ± 0.00 UClH 2 O 10.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 10.00 ± 0.00 UCsbH 2 O 5.00 ± 0.00 2.50 ± 0.00 2.50 ± 0.00 2.50 ± 0.00 UCstH 2 O 5.00 ± 0.00 2.50 ± 0.00 2.50 ± 0.00 2.50 ± 0.00 UCtwEtOH 5.00 ± 0.00 2.50 ± 0.00 2.50 ± 0.00 5.00 ± 0.00 UCtwH 2 O 5.00 ± 0.00 2.50 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 UMtwEtOH 5.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 UMuLEtOH 5.00 ± 0.00 5.00 ± 0.00 10.00 ± 0.00 20.00 ± 0.00 UMustEtOH 10.00 ± 0.00 5.00 ± 0.00 10.00 ± 0.00 20.00 ± 0.00 UMustI 5.00 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 20.00 ± 0.00 UMutwEtOH > 20.00 ± 0.00 > 20.00 ± 0.00 > 20.00 ± 0.00 > 20.00 ± 0.00 UMutwI 20.00 ± 0.00 10.00 ± 0.00 10.00 ± 0.00 20.00 ± 0.00 UALEtOH 10.00 ± 0.00 20.00 ± 0.00 20.00 ± 0.00 10.00 ± 0.00 UALI 10.00 ± 0.00 5.00 ± 0.00 10.00 ± 0.00 10.00 ± 0.00 UALII 2.50 ± 0.00 5.00 ± 0.00 5.00 ± 0.00 10.00 ± 0.00 UAstEtOH 20.00 ± 0.00 5.00 ± 0.00 10.00 ± 0.00 20.00 ± 0.00 UAstI 5.00 ± 0.00 10.00 ± 0.00 5.00 ± 0.00 20.00 ± 0.00 UAtwEtOH 10.00 ± 0.00 10.00 ± 0.00 2.50 ± 0.00 > 20.00 ± 0.00 UAtwI 10.00 ± 0.00 2.50 ± 0.00 2.50 ± 0.00 10.00 ± 0.00 ZXse 5.00 ± 0.00 2.50 ± 0.00 5.00 ± 0.00 10.00 ± 0.00 Chloramphenicol 2.50 ± 0.00 > 10.00 ± 0.00 > 10.00 ± 0.00 5.00 ± 0.00 Results are expressed as mean ± standard deviation; AIlH revealed the presence of phenols, tannins, saponins, triterpenes, and glycosides known to impact the growth and metabolism of microorganisms [40] . Though the detection of such metabolites does not automatically predict the antimicrobial activity of a plant extract, it has clearly been demonstrated that several compounds belonging to the investigated classes of metabolites showed antibacterial activities [40] [41] [42] . Tannins exert its antimicrobial activity by binding with proteins and adhesins, inhibiting enzymes, complexation with the cell wall and metal ions, or disruption of the plasmatic membrane [42] . Flavonoids have the ability to complex with proteins and bacterial cells forming irreversible complexes mainly with nucleophilic amino acids. This complex often leads to inactivation of the protein and loss of its function [43] . The mode of action of saponins against bacteria is due to its ability to cause leakage of proteins and certain enzymes from the cell [44] . The sensitivity of steroids and the membrane lipids indicate their specific association that causes leakage from liposomes. It seems that both active compounds from extracts directly or indirectly attach to the different site on bacterial cell. Mechanism of synergy is still insufficiently researched [45] . Synergy effects of the mixture of bioactive constituents contained in plant extracts are claimed to be responsible for the improved efficiency of many extracts. For a long time, the mechanisms underlying these synergy effects remained unexplained. With the exact knowledge of these mechanisms, it will be possible to develop a new generation of standardized, effect-optimized mono-and multi-extract preparations, which not only fulfill today's standards for quality, safety and efficacy of medicinal drugs but can ideally be used for the treatment of diseases that have been treated previously with chemosynthetics or antibiotics [46] . Synergy research in phytomedicine has established itself as a new key activity in recent years. It is one main aim of this research to find a scientific rational for the therapeutic superiority of many herbal drug extracts derived from traditional medicine as compared with single constituents thereof. For this reasons, the combinations of plant extracts could be a significant basis for the development of new approach to fight against resistance. Then the extracts contain mixtures of different bioactive compounds, which make microbial adaptability very difficult comparing to single-constituent antibiotics [47, 48] .
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Conclusions
The antibacterial activity exhibited by the crude extracts against Staphylococcus aureus, Pseudomonas aeruginosa, Salmonella typhi and Escherichia coli that are associated with various infectious diseases, has provided scientific justification in the use of these plants in Cameroonian folk medicine and could lead new phytomedicine. However, further isolation of active constituents from such plants, determination of their safety and pharmacokinetics properties are required.
